The global biopharmaceutical sector saw a sharp 101% surge in merger and acquisition (M&A) deal value in Q1 2025, reaching $37.7 billion—up from $18.8 billion in Q4 2024—according to GlobalData’s Pharmaceutical Intelligence Center Deals Database. Despite the growth, total deal

IBM CEO Arvind Krishna has revealed that the company’s move to replace segments of its Human Resources (HR) workforce with artificial intelligence (AI) tools has not resulted in job losses but instead led to expanded hiring in areas like programming,